PMI

Bupa and The Patients Association have announced a three-year partnership to help improve access to information for patients and increase patient involvement in decision-making about their healthcare.

Macmillan Cancer Support has been "shocked" by the absence of incentives to improve cancer survival rates in the reformed NHS framework.

Now Health International has announced details of its WorldCare product, including a price review, to take effect from 1 August.

The answer to long-term care funding issues is ongoing with the Dilnot review central to industry debate. The FSA has published final guidance stating a qualification in long-term care will not be required of independent intermediaries post-RDR - what...

Macmillan Cancer Support has welcomed the "greater clarity" around cancer networks in the NHS Commissioning Board Special Authority report on the future of strategic clinical networks.

Amid falling protection sales and a growing protection gap, Pink and Aviva have teamed up to provide a protection training academy for mortgage advisers and people new to the industry. Mark Graves explains why.

The Association of Medical Insurance Intermediaries (Amii) will be lobbying to government for P11D reform with the support of Biba later this year.

Inclusion of overseas treatment options to innovate private medical insurance products may not catch on, Jelf Employee Benefits has said.

PMI policyholders severe pancreatitis could be the first in line to access a new EU gene therapy.

MediCare International has ranked claims in order of prevalence and found a new environment is a major factor in health and claims are far from exotic.